Elamipretide vs Mazdutide
Head-to-head comparison of Elamipretide (Elamipretide (MTP-131, SS-31)) and Mazdutide (IBI362, long-acting GLP-1 receptor and glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Elamipretide | Mazdutide |
|---|---|---|
| Category | Muscle & Performance | Weight Management |
| Full Name | Elamipretide (MTP-131, SS-31) | IBI362, long-acting GLP-1 receptor and glucagon receptor dual agonist |
| Molecular Weight | 639.8 Da | ~5,000 Da |
| Half-Life | 1-4 hours | 5-7 days |
| Amino Acids | 4 | 37 |
| Typical Dose | 0.01-0.25 mg/kg/day | 1-6 mg weekly in obesity trials |
| Route | Subcutaneous/Intravenous | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 120 | 28 |
| Research Status | Clinical | Clinical |
Elamipretide Benefits
- ✓mitochondrial protection
- ✓reduced oxidative stress
- ✓improved fatigue resistance
- ✓may support exercise tolerance
Mazdutide Benefits
- ✓clinically meaningful weight loss
- ✓better glycemic control
- ✓reduced waist circumference
- ✓improved lipid profile
Elamipretide Dosing
0.01-0.25 mg/kg/day SC (clinical research)|daily dosing in trials|alternative IV protocols in some studies
Mazdutide Dosing
Once-weekly SC titration|Dose escalation every 4 weeks|Use with lifestyle modification
Elamipretide Side Effects
- ⚠nausea
- ⚠injection-site reactions
- ⚠diarrhea
- ⚠headache
Mazdutide Side Effects
- ⚠nausea
- ⚠vomiting
- ⚠constipation
Research Overview
Elamipretide
Clinical and translational studies show elamipretide can improve mitochondrial function and some functional endpoints in mitochondrial disorders. Skeletal muscle research suggests benefits are driven by energy metabolism rather than direct muscle-building effects.
Mazdutide
Clinical programs have shown substantial reductions in body weight and improvements in cardiometabolic risk markers. It is a prominent newer dual agonist in the obesity literature.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.